G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers is a paper indexed in PICO Portal from OpenAlex.
How many citations does G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers have?
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers has 104 citations in the OpenAlex counts PICO Portal stores.
When was G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers published?
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers has 2016 year in the PICO Portal index.
What is the open-access status of G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers?
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers has diamond oa status in the PICO Portal index.
What is the DOI of G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers?
The DOI for G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers is on the source record.
What is the PMID of G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers?
The PMID for G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers is on the source record.
What is the OpenAlex record for G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers?
The OpenAlex for G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers is on the source record.